Home › Non-Small Cell Lung Cancer › Rhode Island › Providence
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Providence, RI
Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Providence. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Rhode Island Hospital, Providence
- Roger Williams Medical Center, Providence
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 1/2
- Research Site, Providence
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Rhode Island Hospital, East Providence · 2 mi ang layo
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- Lifespan Cancer Institute, Providence
BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
Nagre-recruitPhase 2
- Rhode Island Hospital, Providence
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Nagre-recruitPhase 3
- Rhode Island Hospital, Providence
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Nagre-recruitPhase 1/2
- Women and Infants Hospital of Rhode Island, Providence
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Nagre-recruitPhase 1
- Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705, Providence
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Nagre-recruitPhase 1/2
- Brown University Health Cancer Institute, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Providence
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
Nagre-recruitPhase 2
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
Nagre-recruitObservasyonal na pag-aaral
- Rhode Island Hospital, Brown University, Providence
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Providence
- Kanser sa Ovary15 pag-aaral
- Kanser ng Endometrium14 pag-aaral
- Obesity14 pag-aaral
- Kanser (lahat ng uri)12 pag-aaral
- Crohn's Disease12 pag-aaral
- Kanser sa Suso11 pag-aaral
- Ulcerative Colitis11 pag-aaral
- Acute Myeloid Leukemia10 pag-aaral
- Metastatic Cancer9 pag-aaral
- Overweight9 pag-aaral
- Alcohol Use Disorder (AUD)8 pag-aaral
- Sakit ni Alzheimer8 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.